Key statistics
On Monday, Ackermans & Van Haaren NV (AVHNF:PKL) closed at 275.00, 0.00% below its 52-week high of 275.00, set on Jan 05, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 275.00 |
|---|---|
| High | 275.00 |
| Low | 275.00 |
| Bid | -- |
| Offer | -- |
| Previous close | 275.00 |
| Average volume | -- |
|---|---|
| Shares outstanding | 33.16m |
| Free float | 21.62m |
| P/E (TTM) | 16.06 |
| Market cap | 9.64bn EUR |
| EPS (TTM) | 18.10 EUR |
| Annual div (ADY) | 4.31 USD |
|---|---|
| Annual div yield (ADY) | 1.57% |
| Div ex-date | May 30 2025 |
| Div pay-date | Jun 02 2025 |
Data delayed at least 15 minutes, as of Jan 05 2026 15:40 GMT.
More ▼
Announcements
- Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)
- Ackermans & van Haaren clôture un excellent exercice 2025 avec un bénéfice net de 593 millions d'euros (+29%)
- Ackermans & van Haaren sluit een succesvol jaar af met een nettowinst van 593 miljoen euro (+29%)
- Ackermans & van Haaren trading update 3T2025: excellents résultats des participations principales, perspectives 2025 confirmées
- Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed
- Ackermans & van Haaren Trading Update 3Q25: uitstekende resultaten van de kernparticipaties, FY2025 vooruitzichten bevestigd
- Ackermans & van Haaren investit 22 millions d'euros dans VKC Nuts
- Ackermans & van Haaren invests 22 million euros in VKC Nuts
- Ackermans & van Haaren investeert 22 miljoen euro in VKC Nuts
- Ackermans & van Haaren soutient le tour de financement de série B de 55 millions d’euros de MRM Health
More ▼
